Hua Medicine (Shanghai)

PharmaceuticalsSeries DShanghai, Chinahuamedicine.com

Latest round

Series D

Last raised

Mar 2018

Total raised

$75M

Investors

16

About Hua Medicine (Shanghai)

Founded in 2010 and based in Shanghai, China, Hua Medicine (Shanghai) Ltd. is a biopharmaceutical company that focuses on developing medical drugs for the treatment of diabetes.

Who invested in Hua Medicine (Shanghai)

16 investors across 3 rounds

See all investors in Hua Medicine (Shanghai)

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Mar 26, 2018

    Amount

    Undisclosed

    Investors

    Locked

  2. Series C

    Apr 22, 2016

    Amount

    $50M

    Investors

    Locked

  3. Series B

    Jan 8, 2015

    Amount

    $25M

    Investors

    Locked

Questions about Hua Medicine (Shanghai)

Who invested in Hua Medicine (Shanghai)?

Hua Medicine (Shanghai) has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hua Medicine (Shanghai) raised?

Hua Medicine (Shanghai) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Hua Medicine (Shanghai) last raise money?

Hua Medicine (Shanghai)'s most recent round on record is a Series D, in Mar 2018.

What does Hua Medicine (Shanghai) do?

Founded in 2010 and based in Shanghai, China, Hua Medicine (Shanghai) Ltd.

Where is Hua Medicine (Shanghai) headquartered?

Hua Medicine (Shanghai) is headquartered in Shanghai, China.

Which VCs invest in companies like Hua Medicine (Shanghai)?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hua Medicine (Shanghai)'s stage. Their profiles are linked below.

Raising like Hua Medicine (Shanghai)? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.